Antibiotic prophylaxis in head and neck surgery;Antibiothérapie prophylactique en chirurgie cervico-faciale

Medecine et Hygiene

Volumn 61, Issue 2454, 2003, Pages 1974-1982

  Dulguerov, Pavor ^a   Harbarth, Stephen ^b   Leuchter, Igor ^a   Pittet, Didier ^b  

^a Service d'Oto Rhino Laryngologie   (Switzerland)

^b Service Prevention et Controle de l'Infection   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AMPICILLIN PLUS CLOXACILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CARBENICILLIN; CEFACLOR; CEFAZOLIN; CEFIXIME; CEFONICID; CEFOPERAZONE; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; CLINDAMYCIN; GENTAMICIN; LATAMOXEF; METICILLIN; METRONIDAZOLE; PENICILLIN DERIVATIVE; PLACEBO; SODIUM CHLORIDE; SULTAMICILLIN; TIMENTIN; UNINDEXED DRUG; VANCOMYCIN;

ANAEROBIC BACTERIUM; ANTIBIOTIC PROPHYLAXIS; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG UTILIZATION; ENDOSCOPIC SURGERY; GRAM POSITIVE BACTERIUM; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HUMAN; IMPLANTATION; NECK DISSECTION; NONHUMAN; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; PREOPERATIVE CARE; REVIEW; SURGICAL INFECTION; TONSILLECTOMY; TREATMENT INDICATION;

EID: 0142215603     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Weber RS, Raad I, Frankenthaler R, et al. Ampicillin-sulbactam vs clindamycin in head and neck oncologic surgery. The need for gram-negative coverage. Arch Otolaryngol Head Neck Surg 1992; 118: 1159-63.
2. Rodrigo JP, Alvarez JC, Gomez JR, et al. Comparison of three prophylactic antibiotic regimens in clean-contaminated head and neck surgery. Head Neck 1997; 19: 188-93.
3. Robbins KT, Byers RM, Cole R, et al. Wound prophylaxis with metronidazole in head and neck surgical oncology. Laryngoscope 1988; 98: 803-6.
4. Blair EA, Johnson JT, Wagner RL, Carrau RL, Bizakis JG. Cost analysis of antibiotic prophylaxis in clean head and neck surgery. Arch Otolaryngol Head Neck Surg 1995; 121: 269-71.
5. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for Prevention of Surgical Site Infection. 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999; 27: 97-132.
6. Grandis JR, Vickers RM, Rihs JD, et al. The efficacy of topical antibiotic prophylaxis for contaminated head and neck surgery. Laryngoscope 1994; 104: 719-24.
7. Burke JF. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 1961; 50: 161-8.
8. Classen DC, Evans RS, Pestotnik SL, et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992; 326: 281-6.
9. McDonald M, Grabsch E, Marshall C, Forbes A. Single-versus multiple-dose antimicrobial prophylaxis for major surgery: A systematic review. Aust N Z J Surg 1998; 68: 388-96.
10. Brand B, Johnson JT, Myers EN, Thearie PB, Sigler BA. Prophylactic perioperative antibiotics in contaminated head and neck surgery. Otolaryngol Head Neck Surg 1982; 90: 315-8.
11. Becker GD, Parell GJ. Cefazolin prophylaxis in head and neck cancer surgery. Ann Otol Rhinol Laryngol 1979; 88: 183-6.
12. Johnson JT, Yu VL, Myers EN, Wagner RL, Sigler BA. Cefazolin vs moxalactam? A double-blind randomized trial of cephalosporins in head and neck surgery. Arch Otolaryngol Head Neck Surg 1986; 112: 151-3.
13. Shapiro M. Prophylaxis in otolaryngologic surgery and neurosurgery: A critical review. Rev Infect Dis 1991; 13 (Suppl. 10): S858-68.
14. Mann W, Maurer J, Wolfensberger M, Riechelmann H, Daschner F. Perioperative Antibiotikaprophylaxie in der Kopf-Hals-Chirurgie. Hno 1990; 38: 197-201.
15. Johnson JT, Wagner RL. Infection following uncontaminated head and neck surgery. Arch Otolaryngol Head Neck Surg 1987; 113: 368-9.
16. Coskun H, Erisen L, Basut O. Factors affecting wound infection rates in head and neck surgery. Otolaryngol Head Neck Surg 2000; 123: 328-33.
17. Reid R, Simcock JW, Chisholm L, Dobbs B, Frizelle FA. Postdischarge clean wound infections: Incidence underestimated and risk factors overemphasized. Aust N Z J Surg 2002; 72: 339-43.
18. Mann W, Maurer J. Perioperative short-term preventive antibiotics in head-neck surgery. Laryngorhinootologie 1990; 69: 158-60.
19. Johnson JT, Weber RS. Prophylaxis for contaminated Head and Neck and cranial base surgery. In: Johnson JT, Yu VL, editors. Infectious diseases and antimicrobial therapy of the ears, nose and throat. Philadelphia: WB Saunders, 1997; 594-8.
20. Lardon N, Dulguerov P, Becker M, et al. Groupes ganglionnaires et évidements cervicaux: nouvelle nomenclature. Med Hyg 1999; 57: 1989-93.
21. Dulguerov P, Udriot B, Lehmann W. Approche et traitement laryngoplastique de la paralysie cordale unilatérale. Med Hyg 1997; 55: 2074-83.
22. Darouiche RO. Antimicrobial approaches for preventing infections associated with surgical implants. Clin Infect Dis 2003; 36: 1284-9.
23. Colreavy MP, Nanan D, Benamer M, et al. Antibiotic prophylaxis post-tonsillectomy: Is it of benefit? Int J Pediatr Otorhinotaryngol 1999; 50: 15-22.
24. Telian SA, Handier SD, Reisher GR, et al. The effect of antibiotic therapy on recovery after tonsillectomy in children. A controlled study. Arch Otolaryngol Head Neck Surg 1986; 112: 610-5.
25. Jones J, Handler SD, Guttenplan M, et al. The efficacy of cefaclor vs amoxicillin on recovery after tonsillectomy in children. Arch Otolaryngol Head Neck Surg 1990; 116: 590-3.
26. Grandis JR, Johnson JT, Vickers RM, et al. The efficacy of perioperative antibiotic therapy on recovery following tonsillectomy in adults: Randomized double-blind placebo-controlled trial. Otolaryngol Head Neck Surg 1992; 106: 137-42.
27. Mann EA, Blair EA, Levy AJ, Chang A. Effect of topical antibiotic therapy on recovery after tonsillectomy in adults. Otolaryngol Head Neck Surg 1999; 121: 277-82.
28. O'Reilly BJ, Black S, Femandes J, Panesar J. Is the routine use of antibiotics justified in adult tonsillectomy? J Laryngol Otol 2003; 117: 382-5.
29. Kujawski O, Dulguerov P, Gysin C, Lehmann W. Microscopic tonsillectomy: A double-blind randomized trial. Otolaryngol Head Neck Surg 1997; 117: 641-7.
30. Callender DL. Antibiotic prophylaxis in head and neck oncologic surgery: The role of gram-negative coverage. Int J Antimicrob Agents 1999; 12 (Suppl. 1): S21-5.
31. Penel N, Lefebvre D, Foumier C, et al. Risk factors for wound infection in head and neck cancer surgery: A prospective study. Head Neck 2001; 23: 447-55.
32. Johanson WG, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med 1969; 281: 1137-40.
33. Becker GD, Parell GJ, Busch DF, et al. The non-value of preoperative and intraoperative cultures in predicting the bacteriology of subsequent wound infection in patients undergoing major head and neck cancer surgery. Laryngoscope 1980; 90: 1933-40.
34. Becker GD, Welch WD. Quantitative bacteriology of intraoperative wound tissue in contaminated surgery. Head Neck 1990; 12: 293-7.
35. Becker GD, Welch WD. Quantitative bacteriology of closed-suction wound drainage in contaminated surgery. Laryngoscope 1990; 100: 403-6.
36. Rubin J, Johnson JT, Wagner RL, Yu VL. Bacteriologic analysis of wound infection following major head and neck surgery. Arch Otolaryngol Head Neck Surg 1988; 114: 969-72.
37. Johnson JT, Myers EN, Thearie PB, Sigler BA, Schramm VL, Jr. Antimicrobial prophylaxis for contaminated head and neck surgery. Laryngoscope 1984; 94: 46-51.
38. Gerard M, Meunier F, Dor P, et al. Antimicrobial prophylaxis for major head and neck surgery in cancer patients. Antimicrob Agents Chemother 1988; 32: 1557-9.
39. Swanson D, Maxwell RA, Johnson JT, Wagner RL, Yu VL. Cefonicid versus clindamycin prophylaxis for head and neck surgery in a randomized, double-blind trial, with pharmacokinetic implications. Antimicrob Agents Chemother 1991; 35: 1360-4.
40. Tandon DA, Bahadur S, Laldina HC, Sundaram KR. Role of prophylactic antibiotics in surgery for advanced head and neck cancer. J Laryngol Otol 1992; 106: 621-4.
41. Fee WE, Jr, Glenn M, Handen C, Hopp ML. One day vs. two days of prophylactic antibiotics in patients undergoing major head and neck surgery. Laryngoscope 1984; 94: 612-4.
42. Johnson JT, Schuller DE, Silver F, et al. Antibiotic prophylaxis in high-risk head and neck surgery: One-day vs. five-day therapy. Otolaryngol Head Neck Surg 1986; 95: 554-7.
43. Mustafa E, Tahsin A. Cefotaxime prophylaxis in major non-contaminated head and neck surgery: One-day vs. seven-day therapy. J Laryngol Otol 1993; 107: 30-2.
44. Righi M, Manfredi R, Fameti G, Pasquini E, Cenacchi V. Short-term versus long-term antimicrobial prophylaxis in oncologic head and neck surgery. Head Neck 1996; 18: 399-404.
45. Carroll WR, Rosenstiel D, Fix JR, et al. Three-dose vs extended-course clindamycin prophylaxis for free-flap reconstruction of the head and neck. Arch Otolaryngol Head Neck Surg 2003; 129: 771-4.
46. Robinson JM. Wound infection following laryngectomy. The effect of topical ampicillin and carbenicillin. J Laryngol Otol 1976; 90: 415-25.
47. Kirchner JC, Edberg SC, Sasaki CT. The use of topical oral antibiotics in head and neck prophylaxis: Is it justified? Laryngoscepe 1988; 98: 26-9.
48. Elledge ES, Whiddon RG, Jr, Fraker JT, Stambaugh KI. The effects of topical oral clindamycin antibiotic rinses on the bacterial content of saliva on healthy human subjects. Otolaryngol Head Neck Surg 1991; 105: 836-9.
49. Grandis JR, Vickers RM, Rihs JD, Yu VL, Johnson JT. Efficacy of topical amoxicillin plus clavulanate/ticarcillin plus clavulanate and clindamycin in contaminated head and neck surgery: Effect of antibiotic spectra and duration of therapy. J Infect Dis 1994; 170: 729-32.
50. Balbuena L, Stambaugh KI, Ramirez SG, Yeager C. Effects of topical oral antiseptic rinses on bacterial counts of saliva in healthy human subjects. Otolaryngol Head Neck Surg 1998; 118: 625-9.
51. Matula C, Hildebrandt M, Nahler G. Decontamination of the oral cavity. Effect of six local anti-microbial preparations in comparison to water and parafilm as controls. J Int Med Res 1988; 16: 98-106.
52. Girod DA, McCulloch TM, Tsue TT, Weymuller EA, Jr. Risk factors for complications in clean-contaminated head and neck surgical procedures. Head Neck 1995; 17: 7-13.
53. Cole RR, Robbins KT, Cohen JI, Wolf PF. A predictive model for wound sepsis in oncologic surgery of the head and neck. Otolaryngol Head Neck Surg 1987; 96: 165-71.
54. Pelczar BT, Weed HG, Schuller DE, Young DC, Reilley TE. Identifying high-risk patients before head and neck oncologic surgery. Arch Otolaryngol Head Neck Surg 1993; 119: 861-4.
55. Robbins KT, Favrot S, Hanna D, Cole R. Risk of wound infection in patients with head and neck cancer. Head Neck 1990; 12: 143-8.
56. Brown BM, Johnson JT, Wagner RL. Etiologic factors in head and neck wound infections. Laryngoscope 1987; 97: 587-90.
57. Johnson JT, Yu VL, Myers EN, et al. Efficacy of two third-generation cephalosporins in prophylaxis for head and neck surgery. Arch Otolaryngol 1984; 110: 224-7.
58. Seagle MB, Duberstein LE, Gross CW, Fletcher JL, Mustafa AQ. Efficacy of cefazolin as a prophylactic antibiotic in head and neck surgery. Otolaryngology 1978; 86: ORL-568-72.
59. Piccart M, Dor P, Klastersky J. Antimicrobial prophylaxis of infections in head and neck cancer surgery. Scand J Infect Dis 1983; 39 (Suppl.): 92-6.
60. Phan M, Van der Auwera P, Andry G, Aoun M, Chantrain G, et al. Antimicrobial prophylaxis for major head and neck surgery in cancer patients: Sulbactam-ampicillin versus clindamycin-amikacin. Antimicrob Agents Chemother 1992; 36: 2014-9.
61. Johnson JT, Kachman K, Wagner RL, Myers EN. Comparison of ampicillin/sulbactam versus clindamycin in the prevention of infection in patients undergoing head and neck surgery. Head Neck 1997; 19: 367-71.